Alexion Pharmaceuticals, Inc.: all contributions
2025–2026 · Reported individual contributions grouped by employer.
These are contributions by individuals, not by their employer, industry, or location. Refunds remain negative; memo-only rows are marked and are not additional money.
← Back to Alexion Pharmaceuticals, Inc.Showing the last prepared contribution list. Updated records are not ready.
| # | Reported contributor / location | Reported employer / occupation | Recipient / reporting committee | Date ↕ | Amount ↑ | Election | Filing details / source |
|---|---|---|---|---|---|---|---|
| 41 | MANSFIELD, CRAIGNEW HAVENCT06510 | EXECUTIVE DIRECTOR GLOBAL HEAD OF SECALEXION PHARMACEUTICALS INC | ALEXION PHARMACEUTICALS INC. PACC00471169 | 2025-11-28 | $10 | Primary (P) | Filing 1928322FEC filing ↗ |
| 42 | MOORE III, EDMUNDSMYRNATN37167 | SENIOR REGIONAL ACCOUNT MANAGER NMOSDALEXION PHARMACEUTICALS INC | ALEXION PHARMACEUTICALS INC. PACC00471169 | 2025-11-28 | $10 | Primary (P) | Filing 1928322FEC filing ↗ |
| 43 | OACHS, DEANROCHESTERMN55906 | US STRATEGIC ACCOUNTS LEAD MINNEAPOLI |
One page is fetched at a time, with one extra row to check for the next page. Current amendment versions are selected before pagination. Raw reported names and filing values are preserved. This list covers locally ingested FEC individual-contribution records, not undisclosed or unitemized contributor identities.